Responses to nondepolarizing neuromuscular blockers and succinylcholine in von Recklinghausen neurofibromatosis

Anesthesia and Analgesia

Volumn 82, Issue 2, 1996, Pages 382-385

  Richardson, Michael G ^a   Setty, Gurudatt K ^a   Rawoof, Schahid A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; SUXAMETHONIUM;

ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DATA BASE; DISEASE CLASSIFICATION; DOMINANT INHERITANCE; DOSE RESPONSE; HUMAN; HYDROCEPHALUS; INTRACRANIAL TUMOR; KYPHOSCOLIOSIS; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PSEUDARTHROSIS; RETROSPECTIVE STUDY; SURGICAL APPROACH;

ANESTHESIA; HUMANS; NEUROFIBROMATOSIS 1; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SUCCINYLCHOLINE;

EID: 0030062618     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199602000-00030     Document Type: Article

References (14)

1. Riccardi VM. The phakomatoses. In: Myrianthopoulos NC, ed. Handbook of clinical neurology. Amsterdam: Elsevier, 1987:365-70.
2. Listernick R, Charrow J. Neurofibromatosis type 1 in childhood. J Pediatr 1990;116:845-53.
3. Stoelting RK, Dierdorf SF. Anesthesia and coexisting disease. New York: Churchill Livingstone, 1993.
4. Manser J. Abnormal responses in von Recklinghausen's disease. Br J Anaesth 1970;42:183.
5. Magbagbeola JAO. Abnormal responses to muscle relaxant in a patient with von Recklinghausen's disease (multiple neurofibromatosis). Br J Anaesth 1970;42:710.
6. Baraka A. Myasthenic response to muscle relaxants in von Recklinghausen's disease. Br J Anaesth 1974;46:701-3.
7. Naguib M, Al-Rajeh SM, Abdulatif M, Ababtin WA. The response of a patient with von Recklinghausen's disease to succinylcholine and atracurium. Middle East J Anesthesiol 1988;9:429-34.
8. Mitterschiffthaler VG, Maurhard U, Huter O, Brezinka C. Verlangerte Wirkung von vecuronium bei neurofibromatose (morbus von Recklinghausen). Anaesthesiol Reanimat 1989;14:175-8.
9. Nagao H, Yamashita M, Shinozaki Y, Oyama T. Hypersensitivity to pancuronium in a patient with von Recklinghausen's disease. Br J Anaesth 1983;55:253.
10. Yamashita M, Matsuki A. Muscle relaxant requirements in patients with von Recklinghausen's disease. Br J Anaesth 1975;47:1032.
11. Fisher MM. Anaesthetic difficulties in neurofibromatosis. Anaesthesia 1975;30:648-50.
12. Donnas M, Mercier FJ, Lhuissier C, Benhamou D. Epidural analgesia for labor in a parturient with neurofibromatosis. Can J Anaesth 1995;42:420-4.
13. Mulvihul JJ, Parry DM, Sherman JL, et al. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 1990;113:39-52.
14. Savarese JJ, Miller RD, Lien CA, Caldwell JE. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, ed. Anesthesia. New York: Churchill Livingstone, 1994:417-89.